Topotecan Injection IP

We, United Biotech (P) Ltd., are a well-known manufacturer, exporter and supplier of quality checked Topotecan Injection IP 2.5mg/2.5ml. To process this medicine, our adroit professionals use best grade chemicals and innovative methodology at our advanced unit. Widely demanded in hospitals and clinics, the provided medicine is specially used to treat patients suffering from lung and ovary cancer. In addition, our valuable clients can buy this Topotecan Injection IP 4mg/4ml from us at marginal prices within committed time frame.

Key points:

• Standard shelf life
• High efficacy
• Free from impurities
• Correct composition

Topotecan Injection IP

Indications :

Metastatic carcinoma of the ovary after failure of initial or subsequent chemotherapy.
Small cell lung cancer after failure of first-line chemotherapy.
Stage IV-B, recurrent or persistent carcinoma of the cervix (which is not amenable to curative treatment with surgery and/or radiation therapy).

Dosage :
Cervical Cancer : IV 0.75 mg/m² daily infused over 30 min on days 1, 2, and 3, followed by IV cisplatin 50 mg/m² infused on day 1 repeated every 21 days.
Ovarian or Small Cell Lung Cancer : IV 1.5 mg/m² /day over 30 min daily for 5 consecutive days starting on day 1 of a 21-day cycle.

Dosage Adjustment :
Renal Impairment : Required.
Hepatic Impairment : No dosage adjustment is required in patients with plasma bilirubin > 1.5 but < 10 mg/dl.

We are also dealing in: